<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(11)</volume><submitter>Biesbroek G</submitter><funding>Anonymous donor through the AMC foundation</funding><funding>Dutch Foundation Kind &amp;amp; Handicap</funding><funding>#wakeuptocorona crowdfund initiative of the Bontius Stichting</funding><funding>Leiden University Fund</funding><pubmed_abstract>Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe inflammatory disease in children related to SARS-CoV-2 with multisystem involvement including marked cardiac dysfunction and clinical symptoms that can resemble Kawasaki Disease (KD). We hypothesized that MIS-C and KD might have commonalities as well as unique inflammatory responses and studied these responses in both diseases. In total, fourteen children with MIS-C (n=8) and KD (n=6) were included in the period of March-June 2020. Clinical and routine blood parameters, cardiac follow-up, SARS-CoV-2-specific antibodies and CD4+ T-cell responses, and cytokine-profiles were determined in both groups. In contrast to KD patients, all MIS-C patients had positive Spike protein-specific CD3+CD4+ T-cell responses. MIS-C and KD patients displayed marked hyper-inflammation with high expression of serum cytokines, including the drug-targetable interleukin (IL)-6 and IFN-γ associated chemokines CXCL9, 10 and 11, which decreased at follow-up. No statistical differences were observed between groups. Clinical outcomes were all favourable without cardiac sequelae at 6 months follow-up. In conclusion, MIS-C and KD-patients both displayed cytokine-associated hyper-inflammation with several high levels of drug-targetable cytokines.</pubmed_abstract><journal>PloS one</journal><pagination>e0266336</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9710748</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study.</pubmed_title><pmcid>PMC9710748</pmcid><pubmed_authors>Ottenhoff THM</pubmed_authors><pubmed_authors>Biesbroek G</pubmed_authors><pubmed_authors>Buddingh EP</pubmed_authors><pubmed_authors>Blink M</pubmed_authors><pubmed_authors>van der Kuip M</pubmed_authors><pubmed_authors>van den Berg JM</pubmed_authors><pubmed_authors>von Asmuth EGJ</pubmed_authors><pubmed_authors>Kuijpers TW</pubmed_authors><pubmed_authors>van Veenendaal M</pubmed_authors><pubmed_authors>Ketharanathan N</pubmed_authors><pubmed_authors>den Boer MEJ</pubmed_authors><pubmed_authors>Joosten SA</pubmed_authors><pubmed_authors>Scherpbier H</pubmed_authors><pubmed_authors>Boele van Hensbroek M</pubmed_authors><pubmed_authors>Peros TE</pubmed_authors><pubmed_authors>Mooij MG</pubmed_authors><pubmed_authors>Brackel CLH</pubmed_authors><pubmed_authors>van Houten MA</pubmed_authors><pubmed_authors>Schonenberg-Meinema D</pubmed_authors><pubmed_authors>Jansen MHA</pubmed_authors><pubmed_authors>Gruppen MP</pubmed_authors><pubmed_authors>van Meijgaarden KE</pubmed_authors><pubmed_authors>Tutu van Furth AM</pubmed_authors><pubmed_authors>van Stijn D</pubmed_authors><pubmed_authors>Kapitein B</pubmed_authors><pubmed_authors>Landman GW</pubmed_authors><pubmed_authors>Zaaijer HL</pubmed_authors><pubmed_authors>Hombrink P</pubmed_authors><pubmed_authors>Kuipers IM</pubmed_authors><pubmed_authors>van der Zee CW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study.</name><description>Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe inflammatory disease in children related to SARS-CoV-2 with multisystem involvement including marked cardiac dysfunction and clinical symptoms that can resemble Kawasaki Disease (KD). We hypothesized that MIS-C and KD might have commonalities as well as unique inflammatory responses and studied these responses in both diseases. In total, fourteen children with MIS-C (n=8) and KD (n=6) were included in the period of March-June 2020. Clinical and routine blood parameters, cardiac follow-up, SARS-CoV-2-specific antibodies and CD4+ T-cell responses, and cytokine-profiles were determined in both groups. In contrast to KD patients, all MIS-C patients had positive Spike protein-specific CD3+CD4+ T-cell responses. MIS-C and KD patients displayed marked hyper-inflammation with high expression of serum cytokines, including the drug-targetable interleukin (IL)-6 and IFN-γ associated chemokines CXCL9, 10 and 11, which decreased at follow-up. No statistical differences were observed between groups. Clinical outcomes were all favourable without cardiac sequelae at 6 months follow-up. In conclusion, MIS-C and KD-patients both displayed cytokine-associated hyper-inflammation with several high levels of drug-targetable cytokines.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T22:15:17.068Z</modification><creation>2025-04-04T22:15:17.068Z</creation></dates><accession>S-EPMC9710748</accession><cross_references><pubmed>36449533</pubmed><doi>10.1371/journal.pone.0266336</doi></cross_references></HashMap>